Filing Details
- Accession Number:
- 0001455244-10-000147
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-17 19:12:30
- Reporting Period:
- 2010-12-15
- Filing Date:
- 2010-12-17
- Accepted Time:
- 2010-12-17 19:12:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
72444 | Nabi Biopharmaceuticals | NABI | Biological Products, (No Disgnostic Substances) (2836) | 591212264 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1376960 | Jason Aryeh | 34 Summer Rd. Greenwich CT 06831 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-12-15 | 1,907 | $5.74 | 179,876 | No | 4 | S | Indirect | Indirect |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Indirect |
Footnotes
- Consists of (i) 17,000 shares owned directly by Mr. Aryeh; and (ii) the remainder of shares benefically owned by Jason Aryeh through his relationship with JALAA Equities, LP, the Jason Aryeh Trust, the Jason Aryeh 2003 Family Trust, and the Jason Aryeh IRA (collectively, the "Aryeh Entities"). Mr. Aryeh disclaims beneficial ownership of all securities held through the Aryeh Entities, except to the extent of any indirect pecuniary interest he may have therein.